NextGen Healthcare, Inc. (NXGN)
Nov 10, 2023 - NXGN was delisted (reason: acquired by Thoma Bravo)
23.94
+0.03 (0.13%)
Last trade price
NextGen Healthcare Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for NextGen Healthcare stock had an average target of 21.98, with a low estimate of 17 and a high estimate of 24.
Analyst Consensus: Buy
* Price targets were last updated on Sep 8, 2023.
Analyst Ratings
The average analyst rating for NXGN stock from 6 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '23 | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 3 | 3 | 3 | 2 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $18 → $24 | Hold | Maintains | $18 → $24 | +0.04% | Sep 8, 2023 |
| RBC Capital | RBC Capital | Hold Maintains $17 → $24 | Hold | Maintains | $17 → $24 | +0.04% | Sep 7, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $21 | Buy | Initiates | $21 | -12.28% | Aug 28, 2023 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | -8.10% | Jul 25, 2023 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $24 | Buy | Reiterates | $24 | +0.25% | Jul 25, 2023 |
Financial Forecast
Revenue This Year
732.42M
from 653.17M
Increased by 12.13%
Revenue Next Year
785.66M
from 732.42M
Increased by 7.27%
EPS This Year
1.12
from -0.04
EPS Next Year
1.36
from 1.12
Increased by 21.27%
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | 756.4M | 820.5M | 868.4M | 922.2M | 985.3M |
| Avg | 732.4M | 785.7M | 839.3M | 895.9M | 957.2M |
| Low | 702.0M | 741.0M | 802.0M | 860.7M | 919.6M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | 15.8% | 12.0% | 10.5% | 9.9% | 10.0% |
| Avg | 12.1% | 7.3% | 6.8% | 6.7% | 6.8% |
| Low | 7.5% | 1.2% | 2.1% | 2.6% | 2.7% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | 1.17 | 1.43 | 1.69 | 1.99 | 2.23 |
| Avg | 1.12 | 1.36 | 1.58 | 1.94 | 2.16 |
| Low | 1.06 | 1.27 | 1.46 | 1.86 | 2.08 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | - | 27.3% | 24.2% | 26.2% | 14.9% |
| Avg | - | 21.3% | 16.2% | 22.6% | 11.6% |
| Low | - | 13.5% | 7.3% | 17.8% | 7.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.